Bausch Health Companies (BHC) Change in Accured Expenses (2009 - 2026)

Bausch Health Companies has reported Change in Accured Expenses for 18 years, with the latest figure at $73.0 million in Q2 2026.

• Quarterly Change in Accured Expenses fell 55.21% year-over-year to $73.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$217.0 million (down 193.53% YoY) and the FY2025 annual result came in at -$76.0 million, down 121.29% from the prior year.
• Change in Accured Expenses improved to $73.0 million in Q2 2026 per BHC's latest filing, from -$150.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $166.0 million in Q3 2023 and troughed at -$284.0 million in Q4 2025.
• A 5-year average of $15.9 million and a median of $48.0 million in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses jumped 737.5% in 2024, then sank 1283.33% in 2025.
• Over 5 years, Change in Accured Expenses stood at $47.0 million in 2022, then jumped by 106.38% to $97.0 million in 2023, then sank by 75.26% to $24.0 million in 2024, then tumbled by 1283.33% to -$284.0 million in 2025, then surged by 125.7% to $73.0 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $73.0 million, -$150.0 million, and -$284.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.